Xun Zhu
Director/Board Member chez SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.
Fortune : 850 008 $ au 31/03/2024
Profil
Xun Zhu is currently serving as an Independent Non-Executive Director at Sihuan Pharmaceutical Holdings Group Ltd., Independent Director at Shenzhen Chipscreen Biosciences Co., Ltd., Deputy Director at China Medicinal Biotech Association, Independent Non-Executive Director at Lansen Pharmaceutical Holdings Ltd., Non-Executive Director at Cathay International Pharmaceutical Ltd., Non-Executive Director at Hightide Therapeutics, Inc., and Member-Life Science Division at National Natural Science Foundation of China.
Dr. Zhu has previously served as an Independent Non-Executive Director at Apollomics, Inc. (United States) and as a Professor at Jilin University from 1994 to 2018.
Dr. Zhu holds a doctorate degree from Norman Bethune Medical University, which was conferred in 1989.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2024 | 856 605 ( 0,17% ) | 646 848 $ | 31/03/2024 | |
| 30/06/2023 | 3 000 000 ( 0,03% ) | 203 160 $ | 31/03/2024 |
Postes actifs de Xun Zhu
| Sociétés | Poste | Début |
|---|---|---|
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Director/Board Member | 20/02/2014 |
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Director/Board Member | 24/03/2018 |
| LANSEN PHARMACEUTICAL HOLDINGS LIMITED | Director/Board Member | 23/09/2022 |
| HIGHTIDE THERAPEUTICS, INC. | Director/Board Member | 30/11/2020 |
| Cathay International Pharmaceutical Ltd. | Director/Board Member | 01/08/2011 |
| China Medicinal Biotech Association | Corporate Officer/Principal | - |
| Norman Bethune Medical University | Corporate Officer/Principal | 01/01/1995 |
| National Natural Science Foundation of China | Corporate Officer/Principal | - |
Anciens postes connus de Xun Zhu
| Sociétés | Poste | Fin |
|---|---|---|
| Jilin University | Corporate Officer/Principal | 01/06/2018 |
| ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Xun Zhu
| Norman Bethune Medical University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Health Technology |
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Health Technology |
| LANSEN PHARMACEUTICAL HOLDINGS LIMITED | Health Technology |
| HIGHTIDE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| China Medicinal Biotech Association | |
| National Natural Science Foundation of China | Government |
| Cathay International Pharmaceutical Ltd. | |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Health Technology |
